- Home
- Clinical Trials
Panic Disorder Study Sydney DH HB
Panic Disorder Study
Darlinghurst Sydney
Do you have panic disorder? Do you experience repeated, unpredictable panic attacks without the presence of a known fear or stressor? Join our clinical trial of a new treatment that looks to normalise the stress response for people with panic disorder.
Register now and find out if this study is right for you.
Description
What to expect
Study details
Ages
18 - 65 years old
Duration
The study has a duration of approximately 15-weeks and involves 6 visits to the clinic and 9 video calls with research staff.
Compensation
Eligible participants will be reimbursed for travel-related costs
Eligibility Criteria
You may be eligible to participate if you:
• Are 18-65 years old with panic disorder.
• Have had a minimum of one full, unexpected panic attack in the week prior to screening for the study.
• Are medically stable on any current medication for at least 3 months.
Please note it is important that study participants remain on any of their current psychiatric medications through the length of the study.
Other inclusion and exclusion criteria apply.
Locations
Description
Panic Disorder is an anxiety disorder characterized by repeated, unpredictable, panic attacks which are experienced without the presence of a known fear of stressor.
Current medicinal treatment options include serotonin and norepinephrine reuptake inhibitors (SSRI/SNRIs) and benzodiazepines (BDZs). However new treatments that safely improve the symptoms of a panic disorder without the adverse effects or serious toxicities of these current medications, are desperately needed.
What to expect
Momentum are conducting a clinical research study investigating a new potential treatment that targets the CNS physiological stress system aiming to normalise the stress response for people with panic disorder. The study aims to demonstrate that the investigational treatment is safer and more tolerable and reduces panic disorder symptoms compared to currently available medicinal treatments.
Please note it is important that study participants remain on any of their current psychiatric medications through the length of the study.
Apply now
Fill out your details, and our team will be in touch to discuss your potential involvement in this study and answer any questions you may have.
*You can unsubscribe or opt out at any time.
- We collect personal information, such as your name, address and contact details, and details of your medical conditions, that enables us to identify if you may be eligible to participate in a current or future study. On occasion we may also contact people on our database by email, with general news and information relevant to our studies and volunteers. By submitting this form you agree to receive email and text notifications about this and other enrolling studies. You can unsubscribe or opt out at any time. We do not sell, share or distribute our database under any circumstances.
- We will collect this information directly from you. If you consent to release of medical records, we will obtain medical information from other agencies on your behalf if these are required for your participation in any clinical study at Momentum Clinical Research.
- Security of your information is important. Personal information collected is stored by third party data storage providers. We believe these providers offer safe and secure systems.
- All information we collect about you will be treated with confidentiality and can be accessed only by Momentum Clinical Research employees.
- By completing our online enrolment form, or any other forms we send you, you agree to us holding your personal details within our databases.
- There is no obligation for you to participate in a study that we contact you about. If you decline to participate in a study, that will not affect your eligibility for participation in another study.